Novel De Novo TRPV4 Mutation Identified in a Chinese Family with Metatropic Dysplasia Inhibits Chondrogenic Differentiation

Ping Wei,Weizhe Shi,Tianying Nong,Caixia Xian,Xia Li,Zhaohui Li,Xin Li,Jianping Wu,Liyuan Shang,Fulong Xu,Yibo Xu,Hongwen Xu,Mingwei Zhu
DOI: https://doi.org/10.1016/j.gendis.2023.05.008
IF: 7.376
2023-01-01
Genes & Diseases
Abstract:Metatropic dysplasia(MD,MIM 156530)is a rare congenital bone dysplasia primarily characterized by severe platy-spondyly with long and wide vertebral bodies and dumbbell deformity of the tubular bones.MD can be caused by het-erozygous mutations in the gene encoding transient re-ceptor potential vanilloid family member 4(TRPV4).We identified a novel de novo mutation,c.2353 T>C,in the TRPV4 gene,in a Chinese family with mild MD.Expression of mutant TRPV4 in HEK293 cells resulted in higher basal intracellular Ca2+concentrations and endoplasmic reticu-lum redistribution.In addition,mutant TRPV4 inhibited the chondrogenic differentiation of ATDC5 cells.Overall,we concluded that the novel mutation c.2353 T>C in the TRPV4 gene was the causative genetic lesion in this MD patient,whilst its pathogenicity might be partially attrib-uted to the inhibition of chondrogenic differentiation.
What problem does this paper attempt to address?